NDC 0270-0556

KINEVAC

Sincalide

KINEVAC is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Bracco Diagnostics Inc.. The primary component is Sincalide.

• Product ID: 0270-0556_66967e85-4512-4b02-9e67-d32284f8acb0
• NDC: 0270-0556
• Product Type: Human Prescription Drug
• Proprietary Name: KINEVAC
• Generic Name: Sincalide
• Dosage Form: Injection, Powder, Lyophilized, For Solution
• Route of Administration: INTRAVENOUS
• Marketing Start Date: 1976-07-21
• Marketing Category: NDA / NDA
• Application Number: NDA017697
• Labeler Name: Bracco Diagnostics Inc.
• Substance Name: SINCALIDE
• Active Ingredient Strength: 5 ug/5mL
• Pharm Classes: Cholecystokinin Analog [EPC], Cholecystokinin [CS]
• NDC Exclude Flag: N
• Listing Certified Through: 2023-12-31

Packaging

NDC 0270-0556-15

10 VIAL in 1 PACKAGE (0270-0556-15) > 5 mL in 1 VIAL

• Marketing Start Date: 1976-07-21
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 0270-0556-15 [00270055615]

KINEVAC INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

• Marketing Category: NDA
• Application Number: NDA017697
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: EA
• Marketing Start Date: 1976-07-21

Drug Details

Active Ingredients

Ingredient	Strength
SINCALIDE	5 ug/5mL

OpenFDA Data

• SPL SET ID: 1408aabb-6982-48e5-ae9f-504ec43b0003
• Manufacturer:
  • Bracco Diagnostics Inc.
• UNII:
  • M03GIQ7Z6P
• RxNorm Concept Unique ID - RxCUI:
  • 208236
  • 237982
• UPC Code:
  • 0302700556154

Pharmacological Class

• Cholecystokinin [CS]
• Cholecystokinin Analog [EPC]
• Cholecystokinin [CS]
• Cholecystokinin Analog [EPC]

NDC Crossover Matching brand name "KINEVAC" or generic name "Sincalide"

NDC	Brand Name	Generic Name
0270-0556	KINEVAC	sincalide
51808-203	SIncalide	Sincalide
70511-131	Sincalide	Sincalide
72266-248	Sincalide	Sincalide